Abstract
1172P - A first-in-class, first-in-human phase I/IIa trial of CAN04, targeting interleukin-1 receptor accessory protein (IL1RAP), in patients with solid tumors
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have